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Abstract 
Background: Prevalence of many eye and ocular surface diseases increases with age. While the clinical characteris-
tics and pathophysiologic mechanisms of these conditions are often either known or extensively studied, the effects 
of normal aging on tear film and ocular surface have not been as widely researched.
Methods: In order to examine the effects of aging on tear fluid proteomics, tear fluid samples were collected preop-
eratively from 115 subjects undergoing strabismus or refractive surgery using glass microcapillary tubes. In addition to 
their refractive error or strabismus, the subjects did not have any other current, known eye diseases. The non-pooled 
samples were analysed using NanoLC-TripleTOF implementing a sequential window acquisition of all theoretical frag-
ment ion spectra mass spectrometry, resulting in quantified data of 849 proteins.
Results: According to correlation results, 17 tear proteins correlated significantly with increased age and many of 
these proteins were connected to inflammation, immune response and cell death. According to enrichment analy-
sis, growth and survival of cells decreased while immune response and inflammation increased with aging. We also 
discovered several well-known, activated and inhibited upstream regulators, e.g. NF-κB, which has been previously 
connected to aging in numerous previous studies.
Conclusions: Overall, the results show the common age-dependent alterations in tear fluid protein profile, which 
demonstrate similar age-associated alterations of biological functions previously shown in other tissue and sample 
types.
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Background
Older age is a major risk factor for various chronic eye 
diseases, such as age-related macular degeneration, glau-
coma, dry eye and other ocular surface diseases [1, 2]. In 
the future, the number of patients with these conditions 
is likely to increase due to population aging but also, in 
the case of ocular surface diseases, due to increased 
use of digital displays and environmental factors such 
as poor air quality. Therefore, there is a need for better 
understanding of normal molecular aging-effects in the 
eye in order to tackle the growing ocular surface issues. 
Fortunately, in recent years, research of ocular surface 
and its molecular functions has advanced due to techno-
logical developments in diagnostic methods. Tear fluid, 
that is nourishing and lubricating the underlying eye, 
provides a non-invasive source for sensitive proteomic 
analyses by means of mass spectrometry to detect puta-
tive biomarkers of ocular surface health.
The normal clinical effects of aging in the eye are rela-
tively well-known and affect all parts of the eye. In ocu-
lar surface of the eye, the tear fluid, consisting of lipid, 
aqueous and mucin layers, which are produced respec-
tively by meibomian glands, lacrimal glands and con-
junctival goblet cells, is known to be altered during aging 
in many ways. Increased age results in lowered tear film 
stability and lacrimal gland secretion [3–9]. Tear film 
composition is also altered [10], similar to meibomian 
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gland-produced lipid profiles [7, 11], while tear evapo-
ration rate is elevated [12]. Despite the various studies 
on the clinical changes, the normal molecular changes 
in aging eye are not yet fully understood. On molecular 
level, increased inflammation and dysregulation of innate 
immune response have been connected to normal aging 
[13, 14] as well as ocular surface conditions [15, 16] and 
hence it can be hypothesised that aging could affect these 
biological pathways in ocular surface as well.
It has been further hypothesised that ocular surface 
aging patterns between women and men are different as 
women are more likely to suffer from age-related ocular 
surface conditions, such as dry eye and Sjögren’s syn-
drome [2, 17, 18]. Some evidence suggests that for exam-
ple the lipid layer, while thinner and more contaminated 
among all elder people, is more affected by age with elder 
women [8] resulting in higher tear evaporation rate [12]. 
One hypothesis to explain the differences between ages 
and sexes, are the shifting levels of sex hormones, which 
have been connected to meibomian and lacrimal gland 
functions [19], and which are more prominent among 
post-menopausal women. However, as ocular surface dis-
eases are often multifactorial, the underlying causes are 
expected to vary and be far more complex.
In this study, we focused on tear film proteomics in 
particular, which we hoped to provide further insight into 
the normal changes in ocular surface during aging and 
possibly also provide further information on the differ-
ences between sexes. Previously, McGill et al. [10] stud-
ied specific tear proteins and their age-related changes 
and discovered that there was an age-associated decline 
in the expression levels of antimicrobial lysozyme, 
lactoferrin and IgA, while ceruloplasmin and IgG were 
increased. More recently, Micera et al. [20] implemented 
protein array data to evaluate age-associated changes in 
tear fluid and confirmed that several pro-inflammatory 
interleukins and other proteins were increased with age. 
Although various age-related diseases have been stud-
ied using tear fluid proteomics [21–23], any wider mass 
spectrometry discovery studies have not been performed 
on the tear fluid proteome changes during normal aging, 
since methods enabling this type of research have only 
been developed quite recently. We gathered tear fluid 
samples from normal, healthy subjects of all ages under-
going either strabismus or refractive surgery and imple-
mented mass spectrometry methods to obtain quantified 
proteomics data on individual patients. Our aims were to 
identify those proteins, which are increasing or decreas-
ing in their expression with increasing age and to see 
how sex of the patient affects these changes. We hypoth-
esized that the statistically significant proteins would be 
connected to age-associated biological functions such as 
immune and inflammatory response. To our knowledge, 
this is the first proteomics study to implement mass spec-
trometry to examine the tear fluid differences among 
people of different ages.
Methods
Study population
Subjects in this study originate from two separate stud-
ies, which implemented these subjects as healthy control 
populations. The subjects of the first study underwent a 
strabismus surgery (n = 30) and the subjects in the sec-
ond study a femtosecond laser in  situ keratomileusis 
(FS-LASIK) (n = 85). In both cases, open-eye tears were 
collected from the lower conjunctival cul-de-sac with 
capillaries prior to any manipulation or anaesthesia of the 
eye, including surgery.
The subjects undergoing refractive surgery had a com-
plete preoperative ophthalmologic examination, includ-
ing biomicroscopy, measurement of corneal thickness 
and three-dimensional corneal topography (Allegro 
Oculyzer, Wavelight AG, Erlangen, Germany) prior to 
the surgery and they had to discontinue wearing soft 
contact lenses at least 1  week before testing. Any ante-
rior or other pathology of the eye that might be a con-
traindication for the refractive surgery, including dry eye 
disease, lid infection, corneal pathology, any prior ocular 
surgery or recent ocular infection, was an exclusion cri-
terion. Other additional exclusion criteria were similar to 
any other refractive surgery: age (under 18 years old) and 
pregnancy. The subjects undergoing strabismus surgery 
similarly had a preoperative ophthalmic examination 
including biomicroscopy, fluorescein staining, conjunc-
tival redness and Schirmer’s test in order to identify any 
clinical pathologies, which would be an exclusion crite-
rion. Similarly, no subjects aged under 18 years or preg-
nant were included.
Tear collection and sample preparation
The tear fluid samples were taken before installation of 
any surgery-associated eye drops. Tear samples were col-
lected into 2 or 3 μl glass microcapillary tubes and stored 
at − 80 °C until assessed.
Samples were flushed from capillaries with 0.5% 
sodium dodecyl sulphate (SDS) in 50  mM ammonium 
bicarbonate supplemented with protease inhibitor cock-
tail and total protein concentration of the tear samples 
was measured by DC protein assay (Bio-Rad laboratories 
Inc, Hercules, USA) using bovine serum albumin as a 
standard. Total protein concentration of 5 µg was consid-
ered as a limit for proteomic analyses. 15 samples did not 
have sufficient amount of protein in the samples.
For protein analysis, acetone-precipitated pro-
teins were dissolved in 2% SDS in 0.05  M triethylam-
monium bicarbonate buffer (TEAB) and reduced by 
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tris-(2-carboxyethyl)phosphine (TCEP) for 1 h at +60 °C. 
The reduced samples were transferred into 10–30  kDa 
molecular weight cut-off filters and flushed with 8  M 
urea in 0.05  M Tris–HCl (Thermo Fisher Scientific, 
Waltham, USA) to remove the excess reagent. Cysteine 
residue blocking was done by iodoacetamide (IAA) at 
room temperature in the dark. Alkylation was terminated 
by centrifugation and the samples were washed with urea 
and 0.05 M TEAB prior to digestion with trypsin (Sciex, 
Framingham, USA) for 16  h at + 37  °C at a trypsin-to-
protein ratio of 1:25. Digests were eluted from filters 
with 0.05  M TEAB followed by 0.5  M NaCl and dried 
in a speed vacuum concentrator. Samples were recon-
stituted in 0.1% trifluoroacetic acid (TFA), cleaned and 
desalted with Pierce C18 tips (Thermo Fisher Scientific) 
according to manufacturer’s instructions. After clean up 
the samples were vacuum dried and stored in − 20  °C 
until reconstituted to loading solution (2% ACN, 0.1% 
FA) at equal concentrations. Unless otherwise stated all 
reagents were purchased from Sigma-Aldrich (St. Louis, 
MO, USA). The samples were analysed with NanoLC-
TripleTOF instrumentation using Eksigent 425 NanoLC 
coupled to high speed TripleTOF™ 5600 + mass spec-
trometer (Sciex, Concord, Canada). The analysis was 
performed using sequential window acquisition of all 
theoretical mass spectra (SWATH-MS). Further detailed 
information of the methods and parameters of NanoLC 
and TripleTOF have been published in our previous 
papers [21, 24].
Protein identification and quantification and SWATH‑MS 
library creation and peak integration
For SWATH-MS analysis method, we created a relative 
protein quantification library, consisting of > 950 pro-
teins. This library was created using tear samples of this 
study as well as two other clinical studies consisting of 
glaucoma patients and dry eye patients. Overall library 
consisted of 55 different subjects/samples and over 80 
data-dependent acquisition (DDA) runs with same liquid 
chromatography (LC) gradient and instrument settings, 
which were used for SWATH-MS analyses. Library was 
created using Protein  Pilot® 4.5 (Sciex, Redwood City, 
USA) and all DDA runs MS/MS spectra were identified 
against UniProtKB/Swiss-Prot. Quantification was per-
formed using  PeakView® and  MarkerView® (Sciex, Red-
wood City, USA). False discovery rate (FDR) of 1% was 
used in the library creation and only distinctive peptides 
were used in the quantification. Retention time cali-
bration was done for all samples using 8 peptides from 
lysozyme and 5 peptides from albumin. Five transitions 
per peptide and 1–15 peptides were used for peak area 
calculations. All proteins with significant or interesting 
findings in the data analysis were subjected to manual 
inspection of peptides. This consisted of checking cor-
rect peak selection in the chromatogram (FDR 1%, 99% 
peptide confidence level), sufficient signal to noise ratio 
inspection (> 7) and chromatogram inspection in rela-
tion to library chromatogram. In addition, variation of 
replicate MS analyses results was calculated as means to 
all samples/protein. If manual inspection requirements 
were not fulfilled, peptides were eliminated from results 
processing. Results are presented as combination of pro-
tein specific peptides peak intensities from SWATH-MS 
measurement and referred to as protein expression.
Data processing and statistical analysis
Log2-transformation and central tendency normalization 
were used to normalize the protein quantification data. 
Majority of the samples had two replicate MS analyses 
run and their variation was calculated by intraclass corre-
lation (ICC package in R) and by permutation tests using 
Spearman’s rank correlation. The replicate MS analyses 
were combined by taking geometric means.
The correlations between age and relative quantifi-
cation data were performed with Pearson’s product-
moment correlation. Ingenuity Pathway Analysis  (IPA®) 
was implemented to evaluate the enriched biologi-
cal functions and diseases based on correlation results 
(included measurements were p-value as “Expr p-value” 
and Pearson’s Rho as “Expr Other”). Sex differences 
were tested using Wilcoxon rank sum test. Benjamini–
Hochberg adjustment was applied to all p-values and 
only proteins with an adjusted p-value below threshold 
(alpha = 0.05) were considered statistically significant 
unless otherwise stated. All statistical analyses for the 
proteomics data were performed using R software ver-
sion 3.4.3 (R Core Team, Vienna, Austria) and QIAGEN’s 
 IPA® (QIAGEN Redwood City, USA).
Results
Clinical patient data
The study consisted of 115 subjects. Tear samples of 30 
subjects undergoing strabismus surgery and 85 undergo-
ing refractive surgery were collected prior to their opera-
tions. None of the subjects had any other current, known 
eye diseases; however, four strabismus surgery subjects 
had previously undergone a cataract surgery. The data 
consisted of 61 females (13 strabismus and 48 refractive 
surgery subjects) and 54 males (17 strabismus and 37 
refractive surgery subjects). The median age for subjects 
was 41  years [95% CI 38–43.9] and ranged from 18 to 
83. The median age for females was 40 [95% CI 37–43.8] 
and for males 42 [95% CI 37.3–46.7]. The age was not sig-
nificantly different between female and male groups was 
(p = 0.6) according to Wilcoxon signed-rank test.
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Proteomics data
We identified 30,358 peptides from 115 samples, includ-
ing MS analysis replicates, corresponding to 660,966 
identified spectra in an assembly of 1497 protein groups 
using FDR of 1.0%. We included 950 proteins with dis-
tinctive peptides to quantification library, of which 849 
proteins had distinct peptide sequences with matching 
spectra to SWATH-MS analysis. These proteins were 
quantified in all samples. The quality checks performed 
with the MS replicate analyses suggested that the prot-
eomic data was of good quality as the mean of intraclass 
correlation coefficient was 0.957 and performing permu-
tation tests (Spearman’s correlation) resulted in 86.6% of 
p-values < 0.05.
Age affects tear proteins associated with inflammation 
and immune response
Tear protein profiles of the analysed 115 subjects were 
used to evaluate the relationship between tear protein 
expression and age as well as sex differences. Age was 
significantly correlated with several well-known tear pro-
teins, many of which were associated with biologically 
important functions such as cell death and inflammatory 
and immune response based on IPA and gene ontology 
(GO) databases (Table 1). The positively correlating pro-
teins included: cytoplasmic actins (ACTB and ACTG1), 
albumin (ALB), annexin A1 (ANXA1), carcinoembryonic 
antigen-related cell adhesion molecule 7 (CEACAM7), 
neutrophil defensin 1 (DEFA1), gelsolin (GSN), neu-
trophil gelatinase-associated lipocalin (LCN2), profi-
lin-1 (PFN1), retinoic acid receptor responder protein 1 
(RARRES1), mammaglobin-A (SCGB2A2), serotransfer-
rin (TF), proteins S100A8 and S100A9. Ubiquitin-like 
modifier-activating enzyme 1 (UBA1) and Golgi mem-
brane protein 1 (GOLM1) correlated negatively with 
age. Further information on the expression level pro-
files of these proteins within different age groups can be 
found from Additional file 1, which also lists the associ-
ated median and mean protein expression values as well 
as interquartile ranges and pairwise t-test p-values for 
patients grouped by age (5 groups: < 30, 30–39, 40–49, 
50–59, and ≥ 60). These results suggest that for majority 
of the statistically significant proteins, the largest changes 
take place among the aging subjects after the age of 60, 
although for some proteins, the changes in expression 
occur already among the 50–59 year-olds’ group.
Although sex alone was not significantly affecting pro-
tein expression levels in tears, some differences were 
observed when the age-affected proteins were ana-
lysed for male and female groups separately (Fig.  1). 
More specifically, the proteins were correlating with 
age similarly among both females and males, but the 
Table 1 List of proteins correlating significantly with age and the associated biological functions
a Pearson’s product-moment correlation coefficient
b Benjamini-Hochberg-adjusted p-value
† Expression based on 1 peptide only
‡ Proteins ACTB and ACTG1 are isoforms of the same protein
Uniprot Full name Symbol Ra pb Cell death Cellular 
movement
Inflammatory/
immune 
response
Viral infection
P80188 Neutrophil gelatinase-associated lipocalin LCN2 0.36 0.011 x x x x
P05109 Protein S100-A8 S100A8 0.40 0.004 x x x x
P06702 Protein S100-A9 S100A9 0.36 0.013 x x x x
P60709 Actin, cytoplasmic 1 ACTB‡ 0.31 0.036 x x x x
P02768 Serum albumin ALB 0.35 0.013 x x x x
P04083 Annexin A1 ANXA1 0.37 0.010 x x x x
P07737 Profilin-1 PFN1 0.32 0.036 x x x
P06396 Gelsolin GSN 0.32 0.036 x x
P02787 Serotransferrin TF 0.37 0.010 x x
P63261 Actin, cytoplasmic 2 ACTG1‡ 0.31 0.037 x
P22314 Ubiquitin-like modifier-activating enzyme 1 UBA1 − 0.32 0.036 x
P59665 Neutrophil defensin 1 DEFA1 0.40 0.004 x x
P49788 Retinoic acid receptor responder protein 1 RARRES1 0.30 0.046 x
Q8NBJ4 Golgi membrane protein 1 GOLM1 − 0.31 0.036 x
Q13296 Mammaglobin-A SCGB2A2 0.34 0.023
Q14002 Carcinoembryonic antigen-related cell 
adhesion molecule 7
CEACAM7† 0.32 0.036
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protein-age-correlations were in most cases statistically 
significant and more consistent with males. SCGB2A2 
was the only protein, which appeared to have a higher 
correlation coefficient for female subjects, while e.g. 
S100A9, ANXA1, GSN and CEACAM7 had notably 
higher age-associated increase for males according to the 
linear regression lines shown in the figure.
The connections between tear proteomics and aging 
(for data including both sexes) were further examined by 
performing pathway analysis. The pathway analysis was 
Fig. 1 Proteins correlating significantly with age. Scatter plots display the statistically significant correlations (from Table 1) between protein 
expression levels (y-axis) and age (x-axis). Correlation results were also evaluated for males and females separately and, unless otherwise stated, only 
males’ expression levels correlated significantly with age for the displayed proteins. The colour and shape of the points signify males and females, 
which also have individual fitted lines and corresponding Rho (R) values displayed. †CEACAM7 expression is based on only 1 unique peptide in the 
data. *p-value < 0.05, **p-value < 0.01, ***p-value < 0.001
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performed on data with relaxed thresholds, more specifi-
cally using proteins with unadjusted p-value < 0.05. Addi-
tional file 1 includes further information about the results 
associated with this protein list. We focused on the 
enriched biological functions and upstream regulators. 
Some of the interesting biological function terms are vis-
ualized and grouped in Fig. 2 and more complete results 
can be found from Table 2. Increased biological functions 
include terms connected to immune response and more 
specifically migration of immune cells. In addition, there 
was evidence of increased inflammatory and cell death 
responses in the tears of elderly subjects. Cell viability 
and survival as well as growth of organism had negative 
z-scores, suggesting inhibition of these functions.
The upstream regulators, which could affect and cause 
the protein expression level changes we have observed in 
the data, are visualized in Fig. 3 and listed in Table 3. The 
three regulators with the highest activation (bias-cor-
rected) z-scores were NF-κB complex, CCAAT/enhancer 
binding protein α (CEBPA) transcription factor and 
interleukin 15 (IL15) and the three molecules with the 
lowest activation z-scores were transcription regulators 
Myc proto-oncogene protein (MYC), cyclin D1 (CCND1) 
and cyclin-dependent kinase 4 and 6 (CDK4/6) group.
Discussion
Although aging is a widely studied subject and noted as a 
major risk factor for many chronic diseases, age-related 
changes in the tear film have not been previously exam-
ined in a molecular level using discovery proteomics. 
Previous research studying tear protein levels during 
aging have mainly focused on individual, well-known 
targeted tear proteins alone. Micera et  al. [20] identi-
fied several pro-inflammatory proteins increasing with 
age through chip arrays and McGill et  al. [10] found a 
decrease of lysozyme, lactoferrin and IgA and an increase 
of ceruloplasmin and IgG in tears during aging in their 
study. In order to obtain more comprehensive image of 
the protein profiles during aging, we analysed the pro-
teomic expression levels of tear fluid samples among 
subjects, both male and female, with varying ages using 
SWATH-MS. The SWATH approach enabled us to per-
form analyses separately in each individual sample, 
avoiding this way pooling of the samples. We discovered 
Fig. 2 Enriched biological functions affected by aging. Heat map displays the general terms (excluding disease-specific terms such as cancer 
terms), which have either highly increased (red) or decreased (green) functions based on activation z-score (absolute bias-corrected z-score > 1.5, 
p-value < 0.05), as age is increased. On the left, the more specific terms are provided for each row and on the right, the specific terms are grouped 
under categories that are more general
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that, among hundreds of proteins, there is a small sub-
group of proteins in tear fluid, which correlated with age 
and many of these proteins were connected to inflamma-
tion, which is known to be increased or at least altered 
with aging [13, 20, 25]. Majority of the identified pro-
teins had the most notable increase/decrease in expres-
sion among subjects aged 60 or over, suggesting that the 
normal onset for the changes often occurs after this age. 
Although the identified protein changes may not directly 
point the specific underlying mechanism that is triggered 
during aging, these results provide a list of interesting 
proteins for future tear fluid proteomic studies associated 
with aging.
Among the proteins, we found age to positively corre-
late with ALB, ANXA1, DEFA1, LCN2, TF, SCGB2A2, 
S100A8 and S100A9. All of these proteins have been 
observed to be increased in the tear fluid proteom-
ics studies examining dry eye disease or other similar 
inflammatory ocular surface conditions [26–34]. Several 
of these proteins, most prominently S100A8 and S100A9, 
are also used as common indicators of ocular surface 
inflammation [26, 35]. Hence, as also suggested by other 
tear fluid proteomic studies [20], it would appear that 
aging does increase the inflammation in the ocular sur-
face and these increased proteins could partially explain 
why higher age is one of the main risk factors of ocular 
surface conditions, which are often closely connected to 
ocular surface inflammation.
Other proteins increasing with age, which could not 
be directly connected to ocular surface inflammation, 
included two cytoplasmic actin isoforms (ACTB and 
ACTG1), GSN, PFN1, CEACAM7 and RARRES1. Of 
these proteins, CEACAM7 and RARRES1 have not yet 
been connected to ocular surface condition and while 
ACTG1 is an interesting protein, it has so far been only 
connected to treatment effects of dry eye [21]. However, 
it merits further investigations of its role in ocular sur-
face functions. ACTB has been found to be decreased 
in the tear fluid of subjects suffering from meibomian 
gland dysfunction [29], yet it was upregulated in Sjögren’s 
syndrome [34], which is often considered to be closer to 
aqueous-deficient dry eye condition. GSN and PFN1 have 
also been shown to be upregulated particularly in aque-
ous-deficient dry eye with and without lipid deficiency, 
but not in lipid-deficient dry eye alone [36]. These pre-
vious findings together with our results suggest that the 
increase of at least some of these proteins would result in 
increased risk of aqueous-deficient dry eye during aging. 
However, age-associated, increased risk of meibomian 
gland-associated lipid deficiency cannot be determined 
based on these results and instead, e.g. lipidomics could 
provide more comprehensive results.
Table 2 Enriched diseases and  biological functions filtered by  activation z-score (absolute bias-corrected z-score > 1.5, 
p-value < 0.05) and ordered based on categories and sign of z-score
Categories Diseases or functions annotation Bias‑corrected z‑score p
Carbohydrate metabolism Uptake of carbohydrate 1.7 6.54E−04
Cardiovascular system development and function Angiogenesis 1.8 4.98E−05
Cell death and survival Cell death of connective tissue cells 2.0 6.98E−04
Cell-to-cell signaling and interaction Response of granulocytes 1.7 2.06E−06
Immune response of leukocytes 1.7 2.60E−03
Cellular function and maintenance Internalization of cells 1.7 3.18E−03
Engulfment of leukocytes 1.6 3.29E−04
Cellular movement Cell movement of myeloid cells 1.7 1.23E−05
Cell movement 1.6 4.22E−07
Chemotaxis 1.6 1.15E−04
Cell movement of neutrophils 2.0 5.20E−05
Chemotaxis of leukocytes 1.7 5.48E−05
Chemotaxis of neutrophils 1.6 1.26E−03
Inflammatory response Inflammatory response 1.7 1.68E−05
Organismal survival Organismal death 2.3 3.17E−05
Cell-to-cell signaling and interaction Aggregation of cells − 1.6 4.10E−05
Cell death and survival Cell viability − 1.8 3.63E−04
Cell survival − 2.4 1.90E−06
Cell death of kidney cell lines − 2.4 2.15E−03
Organismal development Growth of organism − 2.5 6.72E−05
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Our data analysis also resulted in two proteins with a 
significantly decreasing expression with increased age: 
UBA1 and GOLM1. UBA1 has been associated with 
increased expression in the tear fluid of dry eye patients 
with both aqueous and lipid deficiency [36]. GOLM1, 
although there are currently no studies connecting this 
protein to the ocular surface, has been recently asso-
ciated with viral infection and its associated immune 
response [37].
Interestingly, protein-age correlations were in most 
cases more significant with males, i.e. males’ protein 
expression increased/decreased more consistently with 
age. SCGB2A2 was the only protein, which had a some-
what larger correlation coefficient as well as more visible 
increase for female subjects. However, the overall protein 
expression directions were not differing between female 
and male groups, although a previous study by Ananthi 
et al. [38] identified some upregulated proteins in female 
tear samples including lipocalin and mammoglobin B 
precursor, which belongs to the same secretoglobin fam-
ily as SCGB2A2. Clinical studies have also shown that the 
dry eye disease, Sjögren’s syndrome and other ocular sur-
face conditions are more common among older women 
[17, 18], which does suggest that our findings are not 
associated with increasing prevalence of ocular surface 
diseases alone but rather normal aging, which appear 
to be affecting males more significantly. Older women, 
often suffering from ocular surface disease and its symp-
toms, are not fully represented in this study, since they 
are unlikely to participate in ocular surgeries and are in 
fact excluded in severe cases.
The pathway analysis was performed based on the cor-
relation results originating from complete data, in order 
to discover general effects of aging. The results showed 
that while cell survival and organismal growth were 
decreased, organismal death, inflammation, angiogenesis 
Fig. 3 Upstream regulators associated with aging of the ocular surface. The graph displays the top 3 activated (in orange) and inhibited (in 
blue) upstream regulators based on the protein-age-correlation directions obtained. Proteins with increased (in red) and decreased (in green) 
measurements originate from the protein-age-correlation results, i.e. increased measurements suggest a positive correlation between the protein 
expression level and age, and decreased measurements a negative correlation
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and immune response-related actions increased. These 
biological functions display similar results, which have 
already been identified previously [13, 14, 20, 25]. Several 
studies have also discussed of the increased immunose-
nescence, i.e. how the immune system slows down as we 
age, but also that innate immune system is at the same 
time incorrectly activated. Therefore, our results with an 
increase in immune cell chemotaxis and response could 
refer to the increased innate immune response.
The upstream regulators, which are associated with or 
affecting protein expression levels observed in the data 
were also evaluated. Transcription regulator CEBPA, 
cytokine IL15 and NF-κB complex were the top three 
activated upstream regulators and of these, NF-κB 
appears to be the most interesting. This complex is not 
only connecting to or regulating the other upstream 
regulators looked at more closely in this study, but vari-
ous studies and reviews link it to aging, inflammation 
and dry eye. In fact, NF-κB is considered as a hallmark 
of aging and master regulator of innate immunity [39, 
40]. It has also been identified in rat cornea, conjunctiva 
and lacrimal gland [41] and a very comprehensive review 
shows how it links to several ocular surface diseases [42]. 
Our results therefore comply well with the previous find-
ings and suggest that activation of NF-κB is also present 
in the aging ocular surface and its tear fluid. Targeting 
this complex in ocular surface treatment methods could 
provide good results, especially for elder subjects.
Of the two other activated upstream regulators, 
CEBPA has been associated to regulation of aging in 
mouse gene expression as well as fat metabolism [43] and 
it also inhibits CDK4 and therefore cell proliferation and 
growth [44]. IL15, which is closely connected to immune 
system response, has been noted to be increased in the 
sera of subjects above the age of 95 years [45].
The top three inhibited regulators included transcrip-
tion regulators CCND1 and MYC as well as CDK4/6 
group. In fact, CDK4/6 and CCND1 form together a 
complex, which regulates cell cycle [46] and has been for 
that reason covered in various cancer studies. In addi-
tion, MYC has also been connected to the CDK4/6 and 
that way to CCND1 through these cancer studies [47]. 
Table 3 Upstream regulator analysis filtered by  p-value (p-value < 0.05) and  ordered based on  molecule type  and sign 
of z-score
Upstream regulator Molecule type Bias‑corrected z‑score p of overlap
NFκB (complex) Complex 1.5 3.01E−04
IgG Complex 0.5 3.65E−05
IL15 Cytokine 2.2 2.08E−05
IL13 Cytokine 0.9 1.63E−02
IFNG Cytokine 0.1 7.23E−03
IL1B Cytokine 0.1 7.27E−04
TNF Cytokine 0.0 3.60E−09
MGEA5 Enzyme 0.2 3.28E−02
ERK1/2 Group 1.3 8.18E−05
Estrogen receptor Group 0.8 4.54E−03
EGFR Kinase 0.9 2.58E−03
EFNA4 Kinase 0.1 7.28E−05
ESRRA Ligand-dependent nuclear receptor 1.5 3.00E−05
ESR1 Ligand-dependent nuclear receptor 1.0 2.70E−03
PCGEM1 Other 1.1 2.21E−06
EFNA1 Other 0.1 1.82E−04
CEBPA Transcription regulator 2.2 3.28E−07
IL6 Cytokine − 0.4 4.76E−03
TGM2 Enzyme − 0.2 2.29E−02
CDK4/6 Group − 1.4 1.66E−06
MAPK1 Kinase − 0.5 2.71E−03
TP53 Transcription regulator − 0.4 9.19E−03
HIF1A Transcription regulator − 0.5 9.82E−04
MYC Transcription regulator − 1.5 4.88E−05
CCND1 Transcription regulator − 1.6 1.54E−04
SYVN1 Transporter − 0.1 7.30E−04
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Since all three regulators promote growth and regu-
late cell cycle, it seems feasible that these regulators are 
inhibited as our results suggest decreased cell survival 
and organismal growth.
Conclusions
In conclusion, we discovered several tear fluid proteins, 
which are significantly affected by increasing age. These 
proteins are connected to several age-associated func-
tions, e.g. cell death and inflammation, as well as well-
known upstream regulators, NF-κB being one of the most 
interesting of these. In the future tear fluid proteomics 
studies, the information presented here should motivate 
researchers to ensure age is properly controlled for in the 
studies and in addition, the knowledge of the proteins, 
pathways and upstream regulators can be implemented 
in the research of dry eye and other ocular surface dis-
eases, which are associated with increased age.
Additional file
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